Patient Access
Also, telehealth firm Visionflex has partnered with Syndeticom to deploy a new mobile telehealth product.
The tool includes transcription and verbal repeat functions.
Only 1.3% of images included in the public data set included patient ethnicity.
Cue received emergency use authorization for its at-home COVID-19 test in March and went public in September.
The scheme is being run in partnership with government technology firm PUBLIC.
The pair aim to make AI-enhanced diagnostics accessible beyond hospital settings.
The plan, built with Trustmark Health Benefits, is centered on Teladoc’s primary care offering, recently made available to payers.
The mobile platform allows users to access pharmacy services and make appointments, search for drug options and get manufacturer coupons.
A new app which collates older people’s health indicators and monitors for flu symptoms supports nurses and carers to make remote diagnoses and treat patients in their homes, reducing hospitalisations.
The internet cognitive behavioural therapy programme will launch in 2022.